146 related articles for article (PubMed ID: 31903475)
1. Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines.
Fandzloch M; Jaromin A; Zaremba-Czogalla M; Wojtczak A; Lewińska A; Sitkowski J; Wiśniewska J; Łakomska I; Gubernator J
Dalton Trans; 2020 Jan; 49(4):1207-1219. PubMed ID: 31903475
[TBL] [Abstract][Full Text] [Related]
2. Sawhorse-type ruthenium complexes with triazolopyrimidine ligands - what do they represent in terms of cytotoxic and CORM compounds?
Fandzloch M; Jędrzejewski T; Wiśniewska J; Sitkowski J; Dobrzańska L; Brożyna AA; Wrotek S
Dalton Trans; 2022 Jun; 51(22):8804-8820. PubMed ID: 35616922
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
Łakomska I; Hoffmann K; Wojtczak A; Sitkowski J; Maj E; Wietrzyk J
J Inorg Biochem; 2014 Dec; 141():188-197. PubMed ID: 25277461
[TBL] [Abstract][Full Text] [Related]
4. Platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo [1,5-a]pyrimidines: spectroscopical characterization and cytotoxic activity in vitro.
Łakomska I; Fandzloch M; Popławska B; Sitkowski J
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Jun; 91():126-9. PubMed ID: 22366623
[TBL] [Abstract][Full Text] [Related]
5. First dinuclear rhodium(II) complexes with triazolopyrimidines and the prospect of their potential biological use.
Fandzloch M; Augustyniak AW; Dobrzańska L; Jędrzejewski T; Sitkowski J; Wypij M; Golińska P
J Inorg Biochem; 2020 Sep; 210():111072. PubMed ID: 32563102
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, structure and biological evaluation of ruthenium(III) complexes of triazolopyrimidines with anticancer properties.
Fandzloch M; Dobrzańska L; Jędrzejewski T; Jezierska J; Wiśniewska J; Łakomska I
J Biol Inorg Chem; 2020 Feb; 25(1):109-124. PubMed ID: 31741123
[TBL] [Abstract][Full Text] [Related]
7. New organometallic ruthenium(ii) complexes with purine analogs - a wide perspective on their biological application.
Fandzloch M; Jędrzejewski T; Dobrzańska L; Esteban-Parra GM; Wiśniewska J; Paneth A; Paneth P; Sitkowski J
Dalton Trans; 2021 Apr; 50(16):5557-5573. PubMed ID: 33908935
[TBL] [Abstract][Full Text] [Related]
8. Factors Affecting the Stability of Platinum(II) Complexes with 1,2,4-Triazolo[1,5-
Jakubowski M; Łakomska I; Kaszuba A; Wojtczak A; Sitkowski J; Jarzęcki AA
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409016
[TBL] [Abstract][Full Text] [Related]
9. Multinuclear NMR spectroscopy and antitumor activity of novel platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines.
Łakomska I; Szłyk E; Sitkowski J; Kozerski L; Wietrzyk J; Pełczyńska M; Nasulewicz A; Opolski A
J Inorg Biochem; 2004 Jan; 98(1):167-72. PubMed ID: 14659646
[TBL] [Abstract][Full Text] [Related]
10. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.
Łakomska I; Fandzloch M; Muzioł T; Lis T; Jezierska J
Dalton Trans; 2013 May; 42(17):6219-26. PubMed ID: 23328694
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, crystal structures and in vitro antistaphylococcal activity of organotin(IV) derivatives with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidine.
Girasolo MA; Canfora L; Sabatino P; Schillaci D; Foresti E; Rubino S; Ruisi G; Stocco G
J Inorg Biochem; 2012 Jan; 106(1):156-63. PubMed ID: 22119808
[TBL] [Abstract][Full Text] [Related]
13. Mono- and dinuclear platinum(II) compounds with 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine. Structure, cytotoxic activity and reaction with 5'-GMP.
Łakomska I; Kooijman H; Spek AL; Shen WZ; Reedijk J
Dalton Trans; 2009 Dec; (48):10736-41. PubMed ID: 20023903
[TBL] [Abstract][Full Text] [Related]
14. A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer.
Wehbe M; Malhotra A; Anantha M; Roosendaal J; Leung AWY; Plackett D; Edwards K; Gilabert-Oriol R; Bally MB
J Control Release; 2017 Apr; 252():50-61. PubMed ID: 28286316
[TBL] [Abstract][Full Text] [Related]
15. Platinum(II) Complexes with Bulky Disubstitute Triazolopyrimidines as Promising Materials for Anticancer Agents.
Łakomska I; Śmiłowicz D; Jakubowski M; Sitkowski J; Wojtczak A
Materials (Basel); 2020 Nov; 13(23):. PubMed ID: 33255252
[TBL] [Abstract][Full Text] [Related]
16. Structure-cytotoxicity relationship for different types of mononuclear platinum(II) complexes with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine.
Łakomska I; Fandzloch M; Muzioł T; Sitkowski J; Wietrzyk J
J Inorg Biochem; 2012 Oct; 115():100-5. PubMed ID: 22926029
[TBL] [Abstract][Full Text] [Related]
17. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
18. Insights into Structure and Biological Activity of Copper(II) and Zinc(II) Complexes with Triazolopyrimidine Ligands.
Argăseală A; Maxim C; Badea M; Ioniță L; Chifiriuc MC; Rostas AM; Bacalum M; Răileanu M; Ruţă LL; Farcaşanu IC; Iorgulescu EE; Olar R
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164029
[TBL] [Abstract][Full Text] [Related]
19. Introducing the 4-Phenyl-1,2,3-Triazole Moiety as a Versatile Scaffold for the Development of Cytotoxic Ruthenium(II) and Osmium(II) Arene Cyclometalates.
Riedl CA; Flocke LS; Hejl M; Roller A; Klose MH; Jakupec MA; Kandioller W; Keppler BK
Inorg Chem; 2017 Jan; 56(1):528-541. PubMed ID: 27996251
[TBL] [Abstract][Full Text] [Related]
20. An investigation on new ruthenium(II) hydrazone complexes as anticancer agents and their interaction with biomolecules.
Alagesan M; Bhuvanesh NS; Dharmaraj N
Dalton Trans; 2014 Apr; 43(16):6087-99. PubMed ID: 24519473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
